Wed, Apr 30, 2014 5:25 PM
Report on voting rights attached to shares and the share capital
According to rules on disclosing ordinary information a status report is issued on voting rights attached to shares and the share capital of the Company recorded on April 30, 2014.

Egis Pharmaceuticals PLC (the 'Company', having its headquarters at H-1106 Budapest,
Keresztúri út 30-38.), in effort to meet the rules set in point (9) Section 54 of the modified
Capital Market Act (CXX/2001), hereby publishes the following information on voting rights
attached to its shares and on the share capital.

Related file

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox